$ESPR сегодня утром Gary9912 поделился на стоктвитс занимательным видео с выступлением Рогера Ньютона, одного из основателей и генерального директора Esperion с 1998 по 2020 годы.. Смотреть на ю-тубе... /watch?v=66CnbPlFrFU Ниже небольшая часть из описания к видео.. *** Roger Newton has worked for 40+ years in the pharmaceutical and biotech life sciences industries. He is formerly the executive chairman and CSO, and also founder, president/CEO, and director of Esperion Therapeutics, Inc., which has its business offices in Ann Arbor. Prior to these appointments, Roger was senior vice president, Pfizer Global R&D, and director, Esperion Therapeutics, a Pfizer, Inc. company. He was co-founder, president/CEO of the original Esperion founded in July 1998. Under Roger’s leadership and the team’s effort, Esperion built a portfolio of mechanism-based biopharmaceuticals focusing on HDL therapy and small molecule lipid regulating agents.  Esperion was acquired by Pfizer for $1.3 billion in February 2004 (13x cash on cash return) and operated as a separate unit within Pfizer until its closure in May 2007. Pfizer then divested Esperion in May 2008 and Roger restarted the company as an independent enterprise. Roger and the Esperion team raised enough equity financing and venture capital to develop Nexletol (bempedoic acid) from preclinical to FDA approval in February 2020. .... ***